You already know the scale is a poor proxy for how a body actually performs. If you've trained for decades, the more honest questions are whether you can still produce force, move quickly, and recover — and whether the data backs up what you feel.
This is an educational article, not medical advice. The goal here is to give you a clinician-grade view of the functional and laboratory markers a provider may review when someone wants to track healthy aging, not a prescription or a promise of any outcome.
Why function outperforms weight as a longevity signal
Body weight tells you almost nothing about muscle quality, force production, or how efficiently you move. The fields of geroscience and geriatric medicine have spent decades validating *functional* measures instead — markers that correlate with future mobility, independence, and mortality risk across large cohorts.
Two stand out because they are cheap, reproducible, and heavily studied: grip strength and gait speed. A pooled analysis of nearly 34,000 older adults found gait speed was associated with survival across age and sex groups [1]. Grip strength, measured by handheld dynamometry, has been linked in large prospective cohorts with all-cause and cardiovascular outcomes — in the PURE study of nearly 140,000 participants, each 5 kg reduction in grip strength was associated with higher risk of death and cardiovascular events [2].
These are population-level associations, not individual guarantees. But for someone tracking the trajectory of her own training, they offer something the scale can't: a window into the system that actually protects mobility and metabolic health into later decades.
Source: [1] Studenski S, et al. Gait Speed and Survival in Older Adults. JAMA, [2] Leong DP, et al. Prognostic value of grip strength: findings from the PURE study. The Lancet
Grip strength: a proxy for total-body force
Grip strength is not really about your hands. It tracks closely enough with overall muscle strength that researchers use it as a whole-body surrogate, and it's a core component of the operational definition of sarcopenia — age-related loss of muscle mass and function — published by the European Working Group on Sarcopenia in Older People (EWGSOP2) [3].
Under that framework, low grip strength is one of the first flags clinicians look at, with commonly cited cut points around 27 kg for men and 16 kg for women as thresholds prompting further assessment [3]. For a strong midlife woman, the value isn't hitting a minimum — it's establishing *your* baseline now and watching the slope over years. A measured decline can prompt a closer look at training, protein intake, hormones, and recovery long before it becomes clinically obvious.
kg · marker = Women threshold
Source: [3] Cruz-Jentoft AJ, et al. Sarcopenia: revised European consensus (EWGSOP2). Age and Ageing
Gait speed: the "sixth vital sign"
Usual walking speed over a short course (commonly 4 meters) is sometimes called a vital sign of aging because it integrates so many systems at once — neuromuscular, cardiovascular, balance, and cognitive. In the pooled cohort analysis, faster gait speed tracked with longer survival, and a threshold near 0.8 m/s is frequently used as a screening cut point for elevated risk [1][3].
If you're training seriously, your usual gait speed likely sits well above screening thresholds — which is exactly the point of having a baseline. The trend over time, paired with how you feel during and after sessions, is more informative than any single value.
m/s · marker = Screening cut point
Source: [1] Studenski S, et al. Gait Speed and Survival in Older Adults. JAMA, [3] Cruz-Jentoft AJ, et al. Sarcopenia: revised European consensus (EWGSOP2). Age and Ageing
The other functional pieces a provider may review
Grip and gait rarely travel alone. A provider building a functional picture may also consider:
- Chair-stand / sit-to-stand tests — a timed proxy for lower-body power, part of the Short Physical Performance Battery (SPPB) used widely in aging research [3].
- Gait + balance + chair-stand combined (SPPB) — a composite score that has been validated against later disability and mortality.
- Recovery and readiness patterns — how long it takes to feel restored between hard sessions. This is subjective, but when it shifts noticeably, it's worth documenting rather than dismissing.
None of these replace lab work. They contextualize it.
Where bloodwork fits alongside function
Functional tests tell you *what* is changing; labs help explore *why*. For a woman in her late 40s noticing longer recovery, fragmented sleep, and a suspected hormonal shift, an independent provider may consider markers across several systems. Common categories discussed in midlife evaluations include:
- Metabolic and inflammatory context — fasting glucose, HbA1c, lipid panel, and high-sensitivity CRP, which the American College of Cardiology and others use in cardiovascular risk discussions [4].
- Hormonal context — perimenopause is a clinical, symptom-based diagnosis, but the menopausal transition involves measurable shifts in FSH and estradiol over time, as described by the Endocrine Society and the STRAW+10 staging framework [5][6]. Thyroid markers (TSH, often free T4) are frequently reviewed because thyroid dysfunction can mimic perimenopausal symptoms.
- Vitamin D and other nutrient markers relevant to muscle and bone health.
The perimenopause point deserves emphasis for an informed reader: hormone levels in the transition fluctuate substantially from cycle to cycle, which is precisely why a single "normal" result shouldn't be used to dismiss real symptoms [5][6]. A provider who takes the full picture — symptoms, function, and trended labs — into account is doing something different from a single snapshot.
On peptides and other options
If you've read about peptides or hormone therapy in the longevity space, the responsible framing is this: whether any specific therapy is appropriate is a clinical decision an independent licensed provider makes after reviewing your history, labs, and goals. A prescription is never guaranteed.
Some therapies discussed in longevity contexts are available only as compounded preparations. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state. This article does not recommend any specific medication, and it makes no claims about results.
How to use these markers as a clinician would
The practical move is to establish baselines now and track the trend. A single grip measurement or one estradiol value is a data point; a series across months and years is a signal. Pair the objective functional tests with the subjective ones you already track in your own practice — sleep continuity, session-to-session readiness, soreness duration — and bring that record to a provider who will actually engage with it.
That combination — validated functional measures, relevant bloodwork interpreted in context, and your own informed observations — is a far more honest report card on healthy aging than any number on a scale.
Where Velri fits
Velri is a technology and coordination company; it does not provide medical care. Velri can help coordinate lab collection and connect you with an independent, licensed provider group for a telehealth visit, where a provider reviews your labs, history, and goals and decides what, if anything, is clinically appropriate. If a provider writes a prescription, it is filled by an independent, licensed pharmacy. Velri does not guarantee any diagnosis, treatment, or prescription, and nothing here is a substitute for personalized medical advice from your own clinician.
